Blue Jet Healthcare
BLUEJET · Pharma > Pharmaceuticals & Drugs Listing date: Nov. 1, 2023

Stock Price vs Company Growth
1d
0.4%
1w
0.3%
1m
6.7%
3m
20.0%
6m
40.8%
1y
9.2%
all
14.7%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 531 0.4%
513
693
Company Overview

Sales
1,179 Cr
Growth: 52.6%
Profit after Tax
352 Cr
Growth: -1.7%
Mid Cap
9,211 Cr
P/E: 26.1x
Industry P/E: 32.9x
Fundamentals

Sales (Cr) ₹ 1,179
Growth 52.6%
EBITDA 37.3%
P/S 7.8x
Dividend 0.2%
P/E 26.1x
Book Value ₹ 73.6
PEG Ratio 0.5x
ROE 30.2%
P/B 7.2x
Shareholding Pattern

Increase    Decrease    No change
Company Profile Detailed

The company is a global, science-led, pharmaceutical company evolved as Strategic Partner for Collaboration, Development & Manufacturing of advance Pharmaceutical Intermediates and API.
Followers (1)